This one seems terribly undervalued in the 3c range, barely above cash backing, or am I missing something?They seem to have high profile management and backing too.Any ideas as to what it will take to get the SP moving?CheersR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025